A University of Washington (UW) spinout focused on developing vaccines for COVID-19 and other respiratory illnesses says the $100 million in Series B financing it just completed will enable it to ...

With the continuing COVID-19 pandemic, several researchers have brought out candidate vaccines, some of which have undergone human testing. However, it is unclear whether they are genuinely protective ...

Researchers optimized a freeze-drying formulation for HIV-1 Gag virus-like particles using Design of Experiments, showing the ...

Nanomedicine. 2014;9(12):1857-1868. A major area of interest in the field of vaccine development for lung-associated pathogens like influenza is new vaccine strategies that will provide broad serotype ...

Advantages of Utilizing a Light-Scattering Toolbox in Vaccine Development Virus-like particles (VLPs) are biomolecular nanoparticles formed by controlled self-assembly of viral structural proteins.

Studies conducted in mice have shown that the COVID-19 vaccine being developed by researchers at the University of São Paulo's Medical School (FM-USP) in Brazil is safe and efficacious. The vaccine ...

Monoclonal antibodies are those that originate from identical immune cells having a common origin. They are highly effective, non-toxic and can specifically target diseased cells, and are therefore ...

University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like particles (VLPs). These particles mimic the outer protein ...

The lung is a major entry point for many of the most detrimental pathogens to human health. The onslaught of pathogens encountered by the lung is counteracted by protective immune responses that are ...